![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
October 03, 2007 10:39 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today the appointment of James E.K. Hildreth, M.D., a world...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor Forum
October 01, 2007 10:29 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today its CEO, Dr. Janet Greeson, has been invited to speak on a...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan to Host 2007 Annual Meeting October 23, 2007
September 28, 2007 10:09 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it will host its annual shareholders meeting on Tuesday,...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Update: Samaritan Agrees to Amend Due Date to Receive Second Upfront Payment of $8.6 Million From Pharmaplaz for Its HIV Out-Licensing Deal
September 24, 2007 14:25 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today they have amended the due date to October 16, 2007 for...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
EUSA Pharma Signs Exclusive Distribution Agreement With Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
September 20, 2007 10:09 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 20, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive distribution agreement...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
September 18, 2007 09:21 ET
|
Samaritan Pharmaceuticals, Inc.
Three Investigational New Drugs (IND) in Pipeline
- Phase II HIV Drug SP-01A
- Phase I Alzheimer's Drug SP-233 Caprospinol
- Phase II Cushing's syndrome SP-6300
LAS VEGAS, Sept. 18, 2007...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan to Talk Up Its Alzheimer's, HIV and Stem Cell Drugs On NBC Affiliate KVBC Channel 3
August 24, 2007 11:15 ET
|
Samaritan Pharmaceuticals, Inc.
- Don't Miss the CEO of Samaritan On "News 3 At Sunrise"
Sunday, August 26th
- Samaritan is One of Nevada's Largest Pharmaceutical Companies
- Samaritan Videos to Highlight the Substantial...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy
August 21, 2007 09:43 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 21, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
August 16, 2007 11:04 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has exclusively licensed a patent application...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent Office
August 14, 2007 11:10 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 14, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that a patent application entitled "NEUROSTEROIDS AS...